RecruitingPhase 1Phase 2NCT04684602

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions

Sponsor

Thomas Advanced Medical LLC

Enrollment

5,000 participants

Start Date

Jul 9, 2020

Study Type

INTERVENTIONAL

Conditions

Sexual Dysfunction Autoimmune Diseases Neurologic Disorders Diabetes Complications Cardiovascular Disorders Integumentary Disease Musculoskeletal Disorders Neurodegenerative Disorders Pulmonary Disorders Urologic Disorders Viral Illness

Summary

This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial studies the use of mesenchymal stem cells — special cells that can help reduce inflammation and promote healing — to treat a variety of chronic and acute medical conditions. **You may be eligible if...** - You are 18 years or older - You are able to provide informed consent - You are able to attend follow-up visits **You may NOT be eligible if...** - You have an active or recent cancer diagnosis (within the last 2 years) - You are pregnant or breastfeeding - You are unable to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.